Evidence map›Paper›PMID 34558855›Full record

ArticleHepatology communications2022

The Integrated "Multiomics" Landscape at Peak Injury and Resolution From Alcohol-Associated Liver Disease.

Sukanta Das, Xiaodong Ge, Hui Han, Romain Desert, Zhuolun Song, Dipti Athavale, Wei Chen, Harriet Gaskell, Daniel Lantvit, Grace Guzman and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Hepatology communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Sukanta DasDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Xiaodong GeDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Hui HanDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Romain DesertDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Zhuolun SongDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0001-5101-3950
Dipti AthavaleDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Wei ChenDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Harriet GaskellDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Daniel LantvitDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Grace GuzmanDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Natalia NietoDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.ORCID 0000-0002-7941-6804
University of Illinois Chicago · US

Funding

Pathogenic role of hepatocyte-derived high-mobility group box-1 isoforms as potential therapeutic targets to prevent and/or resolve liver fibrosisR01DK111677 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NIETO, NATALIA · 2017 to 2020
$2.0M
High-mobility group box-1 and alcoholic liver diseaseR01AA025907 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NIETO, NATALIA · 2018 to 2022
$1.8M
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver diseaseI01BX005093 · VA · JESSE BROWN VA MEDICAL CENTER · PI NIETO, NATALIA · 2021 to 2025
–
BLRD VA I01 BX005093NIAAA NIH HHS R01 AA025907NIDDK NIH HHS R01 DK111677
6 · The paper itself

Abstract

Alcohol-associated liver disease (ALD) is a significant clinical problem for which the most effective therapy is alcohol abstinence. The two aims of this study were, first, to identify the liver transcriptome, fecal microbiome, and portal serum metabolome at peak injury and during early and late resolution from ALD; and second, to integrate their interactions and understand better the pathogenesis of ALD. To provoke alcohol-induced liver injury, female and male wild-type mice were fed the control or ethanol Lieber-DeCarli diets for 6 weeks. To study early and late resolution, alcohol was withdrawn from the diet and mice were sacrificed after 3 and 14 days, respectively. At peak injury, there was increased signal transducer and activator of transcription (Stat3), Rho-GTPases, Tec kinase and glycoprotein VI (Gp6), and decreased peroxisome proliferator-activated receptor signaling. During resolution from ALD, there was up-regulation of vitamin D receptor/retinoid X receptor, toll-like receptor, p38 and Stat3, and down-regulation of liver X receptor signaling. Females showed significant changes in catabolic pathways, whereas males increased cellular stress, injury, and immune-response pathways that decreased during resolution. The bacterial genus Alistipes and the metabolite dipeptide glycyl-L-leucine increased at peak but decreased during resolution from ALD in both genders. Hepatic induction of mitogen-activated protein kinase (Map3k1) correlated with changes in the microbiome and metabolome at peak but was restored during ALD resolution. Inhibition of MAP3K1 protected from ALD in mice. Conclusion: Alcohol abstinence restores the liver transcriptome, fecal microbiome, and portal serum metabolome in a gender-specific manner. Integration of multiomics data identified Map3k1 as a key gene driving pathogenesis and resolution from ALD.

Indexed as

MetabolomeMicrobiotaTranscriptomeAnimalsCells, CulturedDisease Models, AnimalDown-RegulationFecesFemaleHepatocytesLiver Diseases, AlcoholicMaleMAP Kinase Kinase Kinase 1MiceMice, Inbred C57BLUp-RegulationMap3k1 protein, mouseMAP Kinase Kinase Kinase 1

Identifiers

PMID34558855
PMCPMC8710802
OpenAlexW3196756889

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.